IHE vs. IBIC
IHE (iShares U.S. Pharmaceuticals ETF) and IBIC (iShares iBonds Oct 2026 Term TIPS ETF) are both exchange-traded funds - IHE is a Health & Biotech Equities fund tracking the Dow Jones U.S. Select Pharmaceuticals Index, while IBIC is a Inflation-Protected Bonds fund tracking the ICE 2026 Maturity US Inflation-Linked Treasury Index. Both are passively managed. Over the past year, IHE returned 45.56% vs 4.38% for IBIC. At a correlation of -0.08, they often move in opposite directions. IHE charges 0.42%/yr vs 0.10%/yr for IBIC.
Performance
IHE vs. IBIC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IHE achieves a 9.89% return, which is significantly higher than IBIC's 2.39% return.
IHE
- 1D
- 0.83%
- 1M
- 1.54%
- YTD
- 9.89%
- 6M
- 8.65%
- 1Y
- 45.56%
- 3Y*
- 17.81%
- 5Y*
- 10.40%
- 10Y*
- 8.82%
IBIC
- 1D
- 0.06%
- 1M
- 0.08%
- YTD
- 2.39%
- 6M
- 2.49%
- 1Y
- 4.38%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IHE vs. IBIC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 9.89% | 31.69% | 8.13% | -1.59% |
IBIC iShares iBonds Oct 2026 Term TIPS ETF | 2.39% | 4.96% | 5.25% | 2.17% |
Correlation
The correlation between IHE and IBIC is -0.19, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.19 |
Correlation (All Time) Calculated using the full available price history since Sep 15, 2023 | -0.08 |
The correlation between IHE and IBIC shifts across timeframes, from -0.19 (1 year) to -0.08 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IHE vs. IBIC — Risk / Return Rank
IHE
IBIC
IHE vs. IBIC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Pharmaceuticals ETF (IHE) and iShares iBonds Oct 2026 Term TIPS ETF (IBIC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IHE | IBIC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.28 | ||
| Sortino ratioReturn per unit of downside risk | -5.04 | ||
| Omega ratioGain probability vs. loss probability | 1.45 | 2.21 | -0.76 |
| Calmar ratioReturn relative to maximum drawdown | 5.40 | 16.41 | -11.01 |
| Martin ratioReturn relative to average drawdown | 16.62 | 58.11 | -41.49 |
Loading charts...
Drawdowns
IHE vs. IBIC - Drawdown Comparison
The maximum IHE drawdown since its inception was -38.20%, which is greater than IBIC's maximum drawdown of -0.90%. Use the drawdown chart below to compare losses from any high point for IHE and IBIC.
Loading charts...
Drawdown Indicators
| IHE | IBIC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.20% | -0.90% | -37.30% |
Max Drawdown (1Y)Largest decline over 1 year | -8.47% | -0.27% | -8.20% |
Max Drawdown (3Y)Largest decline over 3 years | -15.92% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -16.03% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -29.59% | — | — |
Current DrawdownCurrent decline from peak | -2.26% | -0.11% | -2.15% |
Average DrawdownAverage peak-to-trough decline | -7.90% | -0.10% | -7.80% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.75% | 0.08% | +2.67% |
Volatility
IHE vs. IBIC - Volatility Comparison
iShares U.S. Pharmaceuticals ETF (IHE) has a higher volatility of 5.20% compared to iShares iBonds Oct 2026 Term TIPS ETF (IBIC) at 0.16%. This indicates that IHE's price experiences larger fluctuations and is considered to be riskier than IBIC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IHE | IBIC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.20% | 0.16% | +5.04% |
Volatility (6M)Calculated over the trailing 6-month period | 12.59% | 0.67% | +11.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.20% | 0.89% | +16.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.27% | 1.57% | +14.70% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.07% | 1.57% | +16.50% |
IHE vs. IBIC - Expense Ratio Comparison
IHE has a 0.42% expense ratio, which is higher than IBIC's 0.10% expense ratio.
Dividends
IHE vs. IBIC - Dividend Comparison
IHE's dividend yield for the trailing twelve months is around 1.58%, less than IBIC's 3.59% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBIC iShares iBonds Oct 2026 Term TIPS ETF | 3.59% | 4.43% | 4.65% | 0.83% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IHE iShares U.S. Pharmaceuticals ETF | 1.58% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
Frequently Asked Questions
IHE and IBIC have a correlation of -0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IHE has higher volatility (5.20%) compared to IBIC (0.16%). In terms of maximum drawdown, IHE dropped -38.20% vs IBIC's -0.90%.
On 1-year performance, IHE leads with 45.56% vs 4.38% for IBIC. On fees, IBIC is cheaper at 0.10% per year. On volatility, IBIC has been the lower-risk option at 0.16%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, IHE has performed better with a 45.56% return vs 4.38%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBIC is cheaper with a 0.10% expense ratio, compared with 0.42% for IHE.
IBIC has the higher dividend yield at 3.59%, compared with 1.58% for IHE.
IHE is categorized as Health & Biotech Equities, while IBIC is Inflation-Protected Bonds. IHE tracks Dow Jones U.S. Select Pharmaceuticals Index, while IBIC tracks ICE 2026 Maturity US Inflation-Linked Treasury Index. Their fees differ too: 0.42% for IHE and 0.10% for IBIC.
IBIC currently has the higher Sharpe Ratio (4.94 vs 2.67), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IHE and IBIC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer